LDRT

RADIATION3 trials

Sponsors

Wuhan University, Sun Yat-sen University, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Conditions

LDRTNasopharangeal CancerNasopharyngeal Cancinoma (NPC)Non-Small Cell Lung CancerPeritoneal Metastasis of Gastric and Colorectal Cancer

Phase 1

LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer

Not yet recruitingNCT07453875

Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityLDRT, Peritoneal Metastasis of Gastric and Colorectal Cancer

Start: 2026-05-01End: 2027-12-30Target: 9Updated: 2026-04-27

Phase 2

SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy

Wuhan UniversityNon-Small Cell Lung Cancer

Start: 2022-03-15End: 2023-10-31Target: 88Updated: 2022-05-02

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

RecruitingNCT07325539

Sun Yat-sen UniversityNasopharangeal Cancer, Nasopharyngeal Cancinoma (NPC)

Start: 2026-01-12End: 2030-01-30Target: 55Updated: 2026-05-22